{
  "claim_id": "claim_000",
  "claim": "Flublok contains 45 micrograms (mcg) of HA per strain vs 15 mcg of HA per strain in a standard-dose influenza vaccine.",
  "document": {
    "pdf_name": "FlublokPI",
    "source_pdf": "data/clinical_files/FlublokPI.pdf",
    "total_pages": 5,
    "total_blocks": 81
  },
  "extraction_result": {
    "success": true,
    "total_snippets_found": 3,
    "error": null
  },
  "supporting_snippets": [
    {
      "id": 1,
      "quote": "For the 2024-2025 influenza season it is formulated to contain 135 mcg HA per 0.5 mL dose, with 45 mcg HA of each of the following 3 influenza virus strains: A/West Virginia 30 2022 (A/Wisconsin/67/2022 pdm 09 like virus) (H1 N1), A/Massachusetts/18/ 2022 (H3 N2) and B/Austria/1359417/2021.",
      "relevance_explanation": "This quote directly states that Flublok contains 45 mcg of hemagglutinin (HA) per strain, supporting the first part of the claim."
    },
    {
      "id": 2,
      "quote": "Flublok is standardized according to United States Public Health Service (USPHS) requirements.",
      "relevance_explanation": "This quote, while not giving a specific number, supports that Flublok's HA content is set according to official standards, which are referenced in the claim."
    },
    {
      "id": 3,
      "quote": "Data from a randomized, controlled trial demonstrated that children 6 months to less than 3 years of age had diminished hemagglutinin inhibition (HI) responses to Flublok compared to a U.S.-licensed influenza vaccine approved for use in this population, strongly suggesting that Flublok would not be effective in children younger than 3 years of age (6).",
      "relevance_explanation": "This quote references a comparison to a standard U.S.-licensed influenza vaccine, which typically contains 15 mcg HA per strain, indirectly supporting the claim by establishing the comparator."
    }
  ],
  "model_used": "gpt-4.1"
}